Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onreltea in Pediatric Facial Capillary Malformations
NCT02764411Phase 3Terminated
- Sponsor
- SickKids
- Start
- Jun 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine in capillary malformation (CM), sponsored by SickKids. Started Jun 2016; status: terminated.
02
Drugs
brimonidine
03
Conditions
capillary malformation (CM)
Beyond the preview
Go deeper on NCT02764411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02764411.